Presidential Regulation No. 13 of 2026 on Health Management

1. Background  

On 11 March 2026, the Government of Indonesia issued Presidential Regulation No. 13 of 2026 on Health Management (Perpres 13/2026), which became into force on the same date. Perpres 13/2026 was issued to implement Articles 21(3) and 416 of Law No. 17 of 2023 on Health and forms part of the broader transformation of Indonesia’s national health system following the enactment of the Health Law in 2023. 

The regulation aims to establish an integrated framework for health management, covering both health efforts and health resources, and to enhance coordination across central, regional, and local governments, as well as relevant stakeholders, including businesses.  

Importantly, Perpres 13/2026 revokes and replaces Presidential Regulation No. 72 of 2012 on the National Health System (Perpres 72/2012), marking a shift from a system‑based framework to a governance‑ and management‑oriented approach to health regulation.  

2. Key changes introduced by Perpres 13/2026 

a. Integrated Health Governance Framework

Unlike the previous National Health System framework under Perpres 72/2012, Perpres 13/2026 emphasises health management as an integrated governance process, aligning policy formulation, implementation, monitoring, and evaluation across governmental levels.  

b. Stronger cross‑sector and multi‑level coordination

Perpres 13/2026 expressly regulates coordination between the central government, provincial governments, regency/municipal governments, and local governments, with the central government retaining supervisory authority to ensure alignment with national health priorities. The regulation allows the central government to conduct evaluations and impose administrative follow‑ups where regional implementation is non‑compliant with national health planning and reporting obligations.  

c. Consolidated regulation of health efforts

The regulation consolidates a wide range of health efforts under a single regulatory framework, including, among others: maternal and child health, nutrition, occupational health, environmental health, pharmaceutical and medical device safety, food and beverage safety, and control of addictive substances. This consolidation signals increased policy coherence across previously fragmented regulatory areas.  

d. Alignment with the 2023 Health Law

Perpres 13/2026 operationalises the mandates of Law No. 17 of 2023 on Health, serving as a key implementing regulation that translates statutory principles into governance mechanisms and administrative responsibilities.  

3. Implications for businesses and other stakeholders

Perpres 13/2026 has cross‑sector implications, particularly for businesses operating in regulated or health‑adjacent industries. The regulation reinforces the expectation that health considerations are embedded in operational planning, not treated solely as sector‑specific compliance issues.  

For business actors, the regulation signals: 

Increased regulatory convergence across health‑related areas (e.g. occupational health, food and beverage safety, pharmaceutical products) 

Closer government supervision and coordination, including potential follow‑up actions where health‑related obligations intersect with public services or workforce management 

Heightened importance of internal governance and reporting frameworks that align with national and regional health policies 

4. Conclusion

Perpres 13/2026 represents a significant structural shift in Indonesia’s health regulatory landscape, reinforcing integrated governance and cross‑sector coordination in line with the Health Law 2023. Businesses operating in or alongside the health sector should treat this regulation as a foundational instrument and proactively assess its impact on their compliance and operational frameworks. 

Clients should review existing compliance mechanisms against the new health management framework, align internal governance and decision‑making with Indonesia’s integrated health governance under the 2023 Health Law, closely monitor forthcoming implementing regulations and technical guidance, and ensure effective cross‑functional coordination among legal, compliance, human resources, and operational teams to address health‑related obligations in a holistic and integrated manner.